Aparito
Generated by Meeveem AI
"Digitising clinical trials through remote patient monitoring and real-world data capture."
Wrexham
•11 - 50 Employees
•Digital Health
About Aparito
Aparito operates a clinical trial platform that brings studies directly to patients wherever they are. The Atom5 eCOA platform captures video assessments, wearable data and patient reported outcomes to support decentralised and hybrid trials, enabling participation from home or clinic. This approach removes geographic barriers for patients living with life-limiting diseases who need access to innovative treatments. The company works with pharmaceutical sponsors to digitise clinical endpoints and unlock real-world evidence. By combining multiple data streams through one platform, Aparito enables more frequent monitoring and richer insights for clinical teams while reducing the burden on patients who no longer need to travel to trial sites.
28
Team Members
2014
Founded
Digital Health
Sector
Hybrid
Work Environment
Our Vision
A world where every patient can access clinical trials regardless of location or mobility, accelerating the development of treatments for life-limiting diseases.
Our Mission
Aparito's mission is to digitise clinical trials and accelerate drug development for patients with life-limiting diseases by supporting patient-centric clinical trials with the Atom5 eCOA platform.